Persistent Asset Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Persistent Asset Partners's BMY Position: Q2 2026 in Review
Persistent Asset Partners opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 50 shares worth $2.88K. The stake represents ﹤0.01% of the portfolio and ranks #782 among its holdings. This is a return to the name: Persistent Asset Partners previously reported a position in BMY as recently as Q3 2025.
Persistent Asset Partners first reported a position in BMY in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.34M in Q3 2025. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Persistent Asset Partners held 50 shares of Bristol-Myers Squibb worth $2.88K as of Q2 2026.
- Bristol-Myers Squibb was a new Persistent Asset Partners position in Q2 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Persistent Asset Partners's portfolio in Q2 2026, its #782 holding.
- Persistent Asset Partners first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 2 quarters since.
- Persistent Asset Partners's Bristol-Myers Squibb position peaked at $1.34M in Q3 2025.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.